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circumference of the vessel). The vascular PTV (PTVv) was 
considered as the CTVv plus an anisotropic margin (5 mm CC, 
3 mm in other directions). The tumor PTV (PTVt) was defined 
as the GTV plus an anisotropic margin (5 mm CC, 3 mm in 
other directions) including the PTVv and excluding the PTVd. 
The following doses were prescribed [in 5 daily fractions (fr)] 
to the PTVs: 30 Gy (6 Gy/fr) to the PTVd, 45 Gy (9 Gy/fr) to 
the PTVv, and 37.5 Gy (7.5 Gy/fr) to the PTVt, respectively. 
Constraints were based on AAPM TG101 recommendations: 
Dmax of PRVduodenum < 32.0 Gy, Dmax of PRVspinal cord < 
30.0 Gy, Dmax of PRVstomach < 32.0%, D700cc liver < 21.0 
Gy, D200 cc kidneys < 17.5 Gy. All plans were generated with 
Masterplan Oncentra TPS and the treatment was delivered 
with a step and shot IMRT technique. The primary end point 
was the rate of patients in whom the constraint Dmean > 90% 
was achieved for the 3 different PTVs. Secondary end points 
were the percentage of patients in whom a PTVv near 
minimum dose (D98%) > 90%, a PTVv D95% > 95%, and a 
median dose (D50%) > 95% were achieved. 
 
Results: PTVv Dmean > 90%, PTVv D2% < 115% and OARs Dmax 
constraints were achieved in all patients. Both PTVv D98% > 
90% and PTVv D95% > 95% were achieved in 6 patients (40%). 
 
Conclusion: Although the objective of PTVv D95% > 95% was 
achieved only in 40% of patients, the study showed that in 
100% of patients it was possible to administer a strongly 
differentiated mean and median dose, and in particular a low 
dose to the overlap region between the target and 
duodenum, a high dose to the site of vascular infiltration, 
and an intermediate dose to the remaining target volume. 
Prospective trials based on clinical application of this 
strategy seems to be justified at least in selected patients. 
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Purpose or Objective: Whole breast irradiation is part of 
breast conservative management for early breast cancer. In 
addition to that boost dose to tumor bed improves local 
recurrence rates and is currently the standard of care. Our 
aim of the current study was to evaluate intensity modulated 
radiation therapy (IMRT) for whole breast versus its 
dosimetric properties of volumetric modulated arc therapy 
(VMAT). 
 
Material and Methods: Eighteen consecutive women with left 
sided breast cancer were taken for this retrospective study. 
IMRT treatment plans were created for patients who already 
received treatment with VMAT. The plans were created in 
Monaco planning system using Monte Carlo (MC) algorithm. 
The Elekta Infinity linear accelerator with Agility MLC is used 
for VMAT delivery. Our clinic uses simultaneous integrated 
boost (SIB) technique to treat whole breast patients. The 
dose prescribed was 60Gy/25# to tumor bed and 45Gy/25# 
for whole breast. The plans were evaluated based on 
QUANTTEC dose-volume protocol. Data were statistically 
analyzed using Wilcoxon Signed Rank test. 
 
Results: VMAT technique statistically significant in target 
coverage and dose conformity than IMRT. In addition to that 
lesser ipsilateral & contra lateral lung dose and reduced 
contra lateral breast dose with VMAT. Critical structures like 
Left descending artery(LAD), Spinal Cord and heart also 
received lower doses with VMAT than IMRT . All the 
dosimetric parameters and its statistical values were 
provided in table1.Statistics shows VMAT more significant for 
LAD, Ipsilateral lung dose and Conformity Index. 
 
 
 
Conclusion: From this study , we infer that, our switch over 
from IMRT to VMAT treatment technique provided better 
dosimetric effect for left sided breast cancer patients. Also 
VMAT provided significant improvement target coverage and 
conformity. It reduced the dose to normal tissues further to 
IMRT. 
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Purpose or Objective: To estimate and compare the risk of 
radiation-induced hepatic toxicity (RIHT) in helical 
tomotherapy and fixed-beam intensity-modulated 
radiotherapy (IMRT) for the treatment of hepatocellular 
carcinoma (HCC). 
 
Material and Methods: Twenty patients with unresectable 
HCC treated with tomotherapy were selected. We performed 
tomotherapy re-planning to reduce the non-target normal 
liver volume receiving a dose of more than 15 Gy (NTNL-
V15Gy), and we created a fixed-beam IMRT plan (FB-P). We 
compared the dosimetric results as well as the estimated 
probability of RIHT among the tomotherapy initial plan (T-IP), 
the tomotherapy re-plan (T-RP), and the FB-P. 
 
Results: Comparing the T-RP and FB-P, the homogeneity 
index was 0.11 better with the T-RP. However, the mean 
NTNL-V15Gy was 6.3% lower with the FB-P. These differences 
result in a decline in the probability of RIHT from 0.216 in 
the T-RP to 0.115 in the FB-P. In patients whose NTNL-V15Gy 
was higher than 43.2% with the T-RP, the probability of RIHT 
markedly reduced from 0.533 to 0.274. 
 
